BSX News

DEADLINE ALERT for LAKE, FBRT, APO, BSX: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Gastrointestinal Stent Market worth $0.82 billion by 2031 | MarketsandMarkets™

BSX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bronstein, Gewirtz & Grossman, LLC Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against Boston Scientific Corporation – BSX

Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX

BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit -- The Gross Law Firm

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Boston Scientific Corporation (BSX)